Clinical Trials List
Protocol NumberF7CBI-1600
Not yet recruiting
2005-02-01 - 2005-12-01
Phase II
Terminated1
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
96 participants
